Rodrigo Anselmo Cazzaniga
Overview
Explore the profile of Rodrigo Anselmo Cazzaniga including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
64
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
de Oliveira Rekowski L, Caldas G, Menezes-Silva L, Santos C, Magalhaes L, Cazzaniga R, et al.
Am J Trop Med Hyg
. 2024 Nov;
112(1):124-127.
PMID: 39499953
This report documents the first known cases of lepromatous leprosy in patients with chronic mucocutaneous candidiasis (CMC) linked to a gain-of-function mutation in the STAT1 gene. Two related patients, a...
2.
Jorge K, Braga M, Cazzaniga R, Santos C, Teixeira M, Gomes K, et al.
Int J Infect Dis
. 2024 Jan;
142:106946.
PMID: 38278287
Objectives: Mycobacterium leprae is able to infect Schwann cells leading to neural damage. Neurotrophins are involved in nervous system plasticity and impact neural integrity during diseases. Investigate the association between...
3.
de Oliveira Rekowsky L, de Oliveira D, Cazzaniga R, Magalhaes L, Albuquerque L, Araujo J, et al.
Trop Med Infect Dis
. 2023 Jul;
8(7).
PMID: 37505653
Neglected tropical diseases encompass a group of chronic and debilitating infectious diseases that primarily affect marginalized populations. Among these diseases, leprosy and leishmaniasis are endemic in numerous countries and can...
4.
Lira Tenorio M, Araujo J, de Melo E, Cazzaniga R, Aragao A, Valois L, et al.
Indian J Dermatol Venereol Leprol
. 2023 Apr;
89(6):834-841.
PMID: 37067141
Background Considering the cross-regulation of Th1 and Th2 responses, we hypothesised that atopic diseases (Th2) inhibit the protective Th1 immune response to Mycobacterium leprae and exacerbates leprosy. Objective In this...
5.
Franco K, Amorim F, Santos M, Rollemberg C, de Oliveira F, Franca A, et al.
Front Immunol
. 2021 Dec;
12:779534.
PMID: 34970264
This is a case series study to evaluate immunological markers associated with schistosomiasis advanced fibrosis, including 69 patients from an endemic area from the State of Sergipe and from the...
6.
Miguel C, da Mota P, Afonso B, Agostinho F, Cazzaniga R, Abreu M, et al.
Braz J Infect Dis
. 2021 Nov;
25(6):101638.
PMID: 34756836
Introduction: Leprosy is an infectious disease caused by Mycobacterium leprae. This study aimed to understand the distribution and impact of Hansen's disease in different regions of Brazil and the outcome...
7.
Bezerra-Santos M, do Vale-Simon M, Barreto A, Cazzaniga R, de Oliveira D, Barrios M, et al.
Front Immunol
. 2019 Jan;
9:2920.
PMID: 30631322
Leprosy is a chronic disease caused by infection that can cause severe neurological complications and physical disabilities. A leprosy-specific vaccine would be an important component within control programs but is...
8.
Fonseca A, Simon M, Cazzaniga R, de Moura T, Pacheco de Almeida R, Duthie M, et al.
Infect Dis Poverty
. 2017 Feb;
6(1):5.
PMID: 28162092
Leprosy is a chronic infectious disease caused by Mycobacterium leprae. According to official reports from 121 countries across five WHO regions, there were 213 899 newly diagnosed cases in 2014....
9.
Figueiredo T, de Lucas R, Cazzaniga R, Franca C, Segato F, Taglialegna R, et al.
Rev Inst Med Trop Sao Paulo
. 2016 Sep;
58:69.
PMID: 27680174
Cryptococcosis is a leading invasive fungal infection in immunocompromised patients. Considering the high prevalence and severity of these infections in immunocompromised patients attended at HC-FMRP-USP, the present research aimed to...